ScholarIQanswers from OpenAlex

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy

PaperCitations, authors & open-access status

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy have?

ScholarIQcitation count

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy has 198 citations in the OpenAlex counts ScholarIQ stores.

When was Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy published?

ScholarIQyear

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy has 2018 year in the ScholarIQ index.

What is the open-access status of Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy?

ScholarIQoa status

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy has green oa status in the ScholarIQ index.

What is the DOI of Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy?

ScholarIQdoi

The DOI for Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy is on the source record.

What is the PMID of Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy?

ScholarIQpmid

The PMID for Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy is on the source record.

What is the OpenAlex record for Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy?

ScholarIQopenalex

The OpenAlex for Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial